Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 04338caa a22006497a 4500 | ||
|---|---|---|---|
| 001 | PAPER-24232 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230607132520.0 | ||
| 008 | 190411s2013 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84881171542 | |
| 024 | 7 | |2 cas |a clopidogrel, 113665-84-2, 120202-66-6, 90055-48-4, 94188-84-8; prasugrel, 150322-43-3, 389574-19-0; Piperazines; Platelet Aggregation Inhibitors; Thiophenes; Ticlopidine, 55142-85-3; clopidogrel, A74586SNO7; prasugrel, 34K66TBT99 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a AJEME | ||
| 100 | 1 | |a Lalor, N. | |
| 245 | 1 | 0 | |a Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel |
| 260 | |c 2013 | ||
| 270 | 1 | 0 | |m Instituto Cardiovascular de Buenos Aires - Sanatorio Anchorena, Blanco Encalada 1543, Buenos Aires, 1428, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Kushner, F.G., Hand, M., Smith Jr., S.C., 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation (2009) Circulation, 120, pp. 2271-2306. , American Heart Association Task Force on Practice Guidelines | ||
| 504 | |a Hamm, C.W., Bassand, J.P., Agewall, S., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) (2011) Eur Heart J, 32, pp. 2999-3054 | ||
| 504 | |a Steg, P.G., James, S.K., Atar, D., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) (2012) Eur Heart J, 33, pp. 2569-2619 | ||
| 504 | |a James, S., Akerblom, A., Cannon, C.P., Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial (2009) Am Heart J, 157, pp. 599-605 | ||
| 504 | |a Wallentin, L., Becker, R.C., Budaj, A., Ticagrelor versus clopidogrel in patients with acute coronary syndromes (2009) N Engl J Med, 361, pp. 1045-1057 | ||
| 593 | |a Instituto Cardiovascular de Buenos Aires - Sanatorio Anchorena, Blanco Encalada 1543, Buenos Aires, 1428, Argentina | ||
| 690 | 1 | 0 | |a CLOPIDOGREL |
| 690 | 1 | 0 | |a PRASUGREL |
| 690 | 1 | 0 | |a ACUTE CORONARY SYNDROME |
| 690 | 1 | 0 | |a DRUG USE |
| 690 | 1 | 0 | |a FOLLOW UP |
| 690 | 1 | 0 | |a HEART INFARCTION |
| 690 | 1 | 0 | |a HOSPITAL ADMISSION |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a LETTER |
| 690 | 1 | 0 | |a MAJOR CLINICAL STUDY |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a TRANSLUMINAL CORONARY ANGIOPLASTY |
| 690 | 1 | 0 | |a ACUTE CORONARY SYNDROME |
| 690 | 1 | 0 | |a FOLLOW-UP STUDIES |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a MYOCARDIAL INFARCTION |
| 690 | 1 | 0 | |a PIPERAZINES |
| 690 | 1 | 0 | |a PLATELET AGGREGATION INHIBITORS |
| 690 | 1 | 0 | |a RISK FACTORS |
| 690 | 1 | 0 | |a THIOPHENES |
| 690 | 1 | 0 | |a TICLOPIDINE |
| 700 | 1 | |a Conde, D. | |
| 700 | 1 | |a Rodriguez, L. | |
| 700 | 1 | |a Elissamburu, P. | |
| 700 | 1 | |a Trivi, M. | |
| 773 | 0 | |d 2013 |g v. 31 |h pp. 1287-1288 |k n. 8 |p Am. J. Emerg. Med. |x 07356757 |t American Journal of Emergency Medicine | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881171542&doi=10.1016%2fj.ajem.2013.05.037&partnerID=40&md5=9676b6d8bba6d685fa955a3a89676751 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajem.2013.05.037 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_07356757_v31_n8_p1287_Lalor |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07356757_v31_n8_p1287_Lalor |y Registro en la Biblioteca Digital |
| 961 | |a paper_07356757_v31_n8_p1287_Lalor |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 85185 | ||